The Globe and Mail reports in its Tuesday, Feb. 4, edition that RBC Dominion Securities analyst Walter Spracklin has reaffirmed his "sector perform" recommendation for Andlauer Healthcare Group. The Globe's David Leeder writes in the Eye On Equities column that Mr. Spracklin boosted his share target to $45 from $42. Analysts on average target the shares at $47.50. Mr. Spracklin says in a note: "We see Andlauer Healthcare Group as being least impacted by tariffs as they have less cross-border sales into the U.S., and we therefore continue to expect Andlauer to command a higher relative valuation premium versus other transportation companies. We took higher our target multiple to 9.5 times (from nine times), which when applied to our unchanged 2026 EBITDA estimate results in our higher price target." The Globe reported on Aug. 2 that Scotia Capital analyst Konark Gupta had reaffirmed his "sector perform" recommendation for Andlauer Healthcare. The shares were then going for $41.55. The Globe reported on Nov. 8 that TD Cowen analyst Tim James continued to rank Andlauer Healthcare "buy." The shares could then be had for $43.